Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models
The Design, Synthesis, and Evaluation of Hypoxia-Activated Prodrugs of the KDAC Inhibitor Panobinostat - preLights
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) | Leukemia
Farydak® (panobinostat) for the Treatment of Multiple Myeloma - Clinical Trials Arena
PPP3CA is a client protein of HSP90 and is protected from proteasomal... | Download Scientific Diagram
Panobinostat: a Histone Deacetylase Inhibitor | Personalized Medicine in Oncology
Panobinostat - Wikiwand
Panobinostat mechanism of action: synergy with bortezomib. a Dual... | Download Scientific Diagram
Cancers | Free Full-Text | HDAC Inhibitors Exert Anti-Myeloma Effects through Multiple Modes of Action | HTML
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG - ScienceDirect
The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma
Cancers | Free Full-Text | HDAC Inhibitors Exert Anti-Myeloma Effects through Multiple Modes of Action | HTML
Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies - Imai - 2016 - Cancer Science - Wiley Online Library
Panobinostat profiling in rat tissue in vivo and ex vivo a, Tissue-TPP... | Download Scientific Diagram
New investigational drugs with single-agent activity in multiple myeloma | Blood Cancer Journal
Salvage therapies in relapsed and/or refractory myeloma: what is curre | OTT
Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies - Imai - 2016 - Cancer Science - Wiley Online Library
Post-translational reduction of Sp1 in MM cells by panobinostat. A. The... | Download Scientific Diagram
The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair | Leukemia
Panobinostat - an overview | ScienceDirect Topics
FARYDAK (panobinostat) for Relapsed Multiple Myeloma - Cancer Therapy Advisor
Pan-HDAC inhibitor panobinostat, as a single agent or in combination with PI3K inhibitor, induces apoptosis in APL cells: An emerging approach to overcome MSC-induced resistance - ScienceDirect
Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors | Future Oncology
Mechanism of action of Pis, immunomodulators, and HDACi. Notes:... | Download Scientific Diagram
